Nociception increases during opioid infusion in opioid receptor triple knock-out mice
暂无分享,去创建一个
J. Pintar | B. Kest | G. Klein | A. Juni | Aaron Juni
[1] K. Rice,et al. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery , 2006, Neuroscience Letters.
[2] B. Kest,et al. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: Evidence for multiple diverse hyperalgesic systems , 2006, Brain Research.
[3] J. Pintar,et al. Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone , 2005, Neuropharmacology.
[4] T. Vanderah,et al. Cholecystokinin in the Rostral Ventromedial Medulla Mediates Opioid-Induced Hyperalgesia and Antinociceptive Tolerance , 2005, The Journal of Neuroscience.
[5] V. Hruby,et al. Antinociceptive and nociceptive actions of opioids. , 2004, Journal of neurobiology.
[6] J. Mogil,et al. Modulation of morphine analgesia by site-specific N-methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time , 2004, Pain.
[7] F. Colpaert,et al. Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance. , 2003, Trends in pharmacological sciences.
[8] Maree T. Smith,et al. Morphine-3-Glucuronide’s Neuro-Excitatory Effects Are Mediated via Indirect Activation of N-Methyl-d-Aspartic Acid Receptors: Mechanistic Studies in Embryonic Cultured Hippocampal Neurones , 2003, Anesthesia and analgesia.
[9] S. C. Armstrong,et al. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, Part II. , 2003, Psychosomatics.
[10] C. Rivat,et al. Opioid-induced hyperalgesia: abnormal or normal pain? , 2003, Neuroreport.
[11] J. Mogil,et al. Genetic variation in morphine analgesic tolerance A survey of 11 inbred mouse strains , 2002, Pharmacology Biochemistry and Behavior.
[12] J. Pintar,et al. Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice , 2002, The European journal of neuroscience.
[13] J. Mao,et al. Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity , 2022 .
[14] K. Shen,et al. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence , 2001, Brain Research.
[15] P. Popik,et al. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. , 2001, European journal of pharmacology.
[16] T. Vanderah,et al. Tonic Descending Facilitation from the Rostral Ventromedial Medulla Mediates Opioid-Induced Abnormal Pain and Antinociceptive Tolerance , 2001, The Journal of Neuroscience.
[17] E. Zhang,et al. Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance , 2000, The Journal of Neuroscience.
[18] A. Dahan,et al. Gender Differences in Opioid-mediated Analgesia: Animal and Human Studies , 2000, Anesthesiology.
[19] K. Shen,et al. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability , 2000, PAIN®.
[20] S. Hansen,et al. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long‐term administration?: Six case histories , 1998, Acta anaesthesiologica Scandinavica.
[21] U. Lendahl. Transgenic analysis of central nervous system development and regeneration , 1997, Acta anaesthesiologica Scandinavica. Supplementum.
[22] A. Basbaum,et al. NMDA-receptor regulation of substance P release from primary afferent nociceptors , 1997, Nature.
[23] D. Price,et al. Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactions , 1995, Pain.
[24] Y. Jan,et al. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Dodd,et al. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. , 1994, Pharmacology & toxicology.
[26] D. Price,et al. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] A. Caraceni,et al. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine , 1991, Pain.
[28] N. Hanioka,et al. Species difference of site-selective glucuronidation of morphine. , 1991, Journal of pharmacobio-dynamics.
[29] N. Rawal,et al. Clinical experience of long–term treatment with epidural and intrathecal opioids – a nationwide survey , 1988 .
[30] T. Yaksh,et al. High Doses of Spinal Morphine Produce a Nonopiate Receptormediated Hyperesthesia: Clinical and Theoretic Implications , 1986, Anesthesiology.
[31] M. Kavaliers,et al. Daily rhythms of analgesia in mice: effects of age and photoperiod , 1983, Brain Research.
[32] C. Woolf. Intrathecal high dose morphine produces hyperalgesia in the rat , 1981, Brain Research.
[33] C. Pinsky,et al. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity , 1979, Brain Research.
[34] Fred E. D'Amour,et al. A METHOD FOR DETERMINING LOSS OF PAIN SENSATION , 1941 .
[35] D. Carr,et al. Morphine-3-glucuronide: silent regulator of morphine actions. , 1994, Life sciences.
[36] S. Bartlett,et al. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. , 1994, Life sciences.
[37] A. Somogyi,et al. Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.
[38] L. Hammar,et al. Morphine metabolism in mouse brain. , 1986, NIDA research monograph.